Literature DB >> 7826208

Application of a transformed cell line constitutively expressing HSV-1 polypeptides for the detection of HSV antibodies in human sera by an enzyme immunoassay.

A Sivropoulou1, A Vasilaki, M Arsenakis.   

Abstract

We have previously reported the construction of a cell line BA4, constitutively producing the glycoproteins gD, gG, and alpha 4, the major regulatory protein of HSV-1. These cells have been selected in stepwise increasing concentrations of methotrexate and shown to produce much higher amounts of gD than non-selected cells. Extracts of the selected cells were used in an enzyme linked immunosorbent assay to detect HSV antibodies in human sera obtained from Greek blood donors. We report here that (i) the assay developed is able to distinguish HSV antibody positive from negative human sera and (ii) that its application in an epidemiological survey showed that the incidence of HSV infection in the general population in Greece is 90.4%.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826208     DOI: 10.1007/bf01309463

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Evidence for persistence of infectious agents in isolated human populations.

Authors:  F L Black; W J Hierholzer; F Pinheiro; A S Evans; J P Woodall; E M Opton; J E Emmons; B S West; G Edsall; W G Downs; G D Wallace
Journal:  Am J Epidemiol       Date:  1974-09       Impact factor: 4.897

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells.

Authors:  F W Alt; R E Kellems; J R Bertino; R T Schimke
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

4.  Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.

Authors:  K L Rosenthal; J R Smiley; S South; D C Johnson
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

5.  Antibody response of the newborn after herpes simplex virus infection.

Authors:  J Kahlon; R J Whitley
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

6.  Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.

Authors:  E Paoletti; B R Lipinskas; C Samsonoff; S Mercer; D Panicali
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Specificity of the immune response of mice to herpes simplex virus glycoproteins B and D constitutively expressed on L cell lines.

Authors:  B A Blacklaws; A A Nash; G Darby
Journal:  J Gen Virol       Date:  1987-04       Impact factor: 3.891

8.  Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus.

Authors:  N C Strynadka; M J Redmond; J M Parker; D G Scraba; R S Hodges
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

9.  Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.

Authors:  J F Rooney; C Wohlenberg; K J Cremer; B Moss; A L Notkins
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

10.  The herpes simplex virus type 1 US7 gene product is a 66K glycoprotein and is a target for complement-dependent virus neutralization.

Authors:  V Sullivan; G L Smith
Journal:  J Gen Virol       Date:  1988-04       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.